OBJECTIVES: We compared the influence of substance abuse with that of other comorbidities (e.g., anxiety, HIV) among people with mood disorder (N=129,524) to explore risk factors for psychiatric hospitalization and early readmission within 3 months of discharge. METHODS: After linking Medicaid claims data in 5 states (California, Florida, New Jersey, New York, and Texas) to community-level information, we used logistic and Cox regression to examine hospitalization risk factors. RESULTS: Twenty-four percent of beneficiaries with mood disorder were hospitalized. Of these, 24% were rehospitalized after discharge. Those with comorbid substance abuse accounted for 36% of all baseline hospitalizations and half of all readmissions. CONCLUSIONS: Results highlight the need for increased and sustained funding for the treatment of comorbid substance abuse and mood disorder, and for enhanced partnership between mental health and substance abuse professionals.
OBJECTIVES: We compared the influence of substance abuse with that of other comorbidities (e.g., anxiety, HIV) among people with mood disorder (N=129,524) to explore risk factors for psychiatric hospitalization and early readmission within 3 months of discharge. METHODS: After linking Medicaid claims data in 5 states (California, Florida, New Jersey, New York, and Texas) to community-level information, we used logistic and Cox regression to examine hospitalization risk factors. RESULTS: Twenty-four percent of beneficiaries with mood disorder were hospitalized. Of these, 24% were rehospitalized after discharge. Those with comorbid substance abuse accounted for 36% of all baseline hospitalizations and half of all readmissions. CONCLUSIONS: Results highlight the need for increased and sustained funding for the treatment of comorbid substance abuse and mood disorder, and for enhanced partnership between mental health and substance abuse professionals.
Authors: Caroline P Carney; Robert F Woolson; Laura Jones; Russell Noyes; Bradley N Doebbeling Journal: Psychosom Med Date: 2004 Sep-Oct Impact factor: 4.312
Authors: Khrista R Boylan; Peter J Bieling; Michael Marriott; Helen Begin; L Trevor Young; Glenda M MacQueen Journal: J Clin Psychiatry Date: 2004-08 Impact factor: 4.384
Authors: Michael S Hendryx; Joan E Russo; Bruce Stegner; Dennis G Dyck; Richard K Ries; Peter Roy-Byrne Journal: J Behav Health Serv Res Date: 2003 Jul-Sep Impact factor: 1.505
Authors: Willem A Nolen; David A Luckenbaugh; Lori L Altshuler; Trisha Suppes; Susan L McElroy; Mark A Frye; Ralph W Kupka; Paul E Keck; Gabriele S Leverich; Robert M Post Journal: Am J Psychiatry Date: 2004-08 Impact factor: 18.112
Authors: Alexander Y Walley; Michael Paasche-Orlow; Eugene C Lee; Shaula Forsythe; Veerappa K Chetty; Suzanne Mitchell; Brian W Jack Journal: J Addict Med Date: 2012-03 Impact factor: 3.702
Authors: Derek D Satre; Sujaya Parthasarathy; Kelly C Young-Wolff; Meredith C Meacham; Brian Borsari; Matthew E Hirschtritt; Lucas Van Dyke; Stacy A Sterling Journal: J Stud Alcohol Drugs Date: 2022-09 Impact factor: 3.346
Authors: Shari L Hutchison; Jenny V Flanagan; Irina Karpov; Lisa Elliott; Brandi Holsinger; Jamie Edwards; David Loveland Journal: J Behav Health Serv Res Date: 2019-07 Impact factor: 1.505